In a report released yesterday, Stephen Anderson from Maxim Group maintained a Buy rating on Famous Dave’s Of America (DAVE – Research Report), with a price target of $8. The company’s shares closed yesterday at $3.96, close to its 52-week low of $3.60.

Anderson wrote:

“We maintain our Buy rating and $8 price target on Famous Dave’s (DAVE) following the release of 1Q19 (March) results.”

According to TipRanks.com, Anderson is a 5-star analyst with an average return of 9.9% and a 69.0%…

Related Posts

In a report released today, Brian Nagel from Oppenheimer maintained a Buy rating on Weight Watchers International (WTW – Research Report), with a price target of $40. The company’s shares closed yesterday at $29.88, close to its 52-week low of $27.97. Nagel noted: “We stick with our Outperform rating on…

In a report released yesterday, Joe Gomes from Noble Financial maintained a Buy rating on Comtech Telecommunications (CMTL – Research Report), with a price target of $38. The company’s shares opened today at $22.66, close to its 52-week low of $22. According to TipRanks.com, Gomes is a 2-star analyst with…

In a report released yesterday, Ki Bin Kim from SunTrust Robinson reiterated a Buy rating on Regency Centers (REG – Research Report), with a price target of $70. The company’s shares closed yesterday at $65.88, close to its 52-week high of $67.10. According to TipRanks.com, Kim is a 4-star analyst…

B.Riley FBR analyst Susan Anderson maintained a Hold rating on Tailored Brands (TLRD – Research Report) on May 17 and set a price target of $10. The company’s shares closed on Friday at $7.15, close to its 52-week low of $7.09. According to TipRanks.com, Anderson is a 3-star analyst with…

Maxim Group analyst Jason McCarthy maintained a Buy rating on Agile Therapeutics (AGRX – Research Report) yesterday and set a price target of $3. The company’s shares closed yesterday at $1.41. McCarthy wrote: “Agile Therapeutics announced that the NDA for Twirla (low-dose contraceptive patch) has been resubmitted to the FDA.…